GlaxoSmithKline PLC: Notifiable Share Interest in | Company Announcements

Tuesday 05 January, 2010

GlaxoSmithKline PLC

Notifiable Share Interest in

RNS Number : 0078F

GlaxoSmithKline PLC

04 January 2010

Notifiable Share Interest in Maxygen, Inc.

GlaxoSmithKline plc ("GSK") announces that on 30 December 2009 GSK sold 5,121,488 Common shares of Maxygen, Inc. ("Maxygen"), a biopharmaceutical company focused on developing improved versions of protein drugs, located in the United States and whose shares are traded on the NASDAQ Exchange.

GSK's interest, which is held by Glaxo Group Limited and GlaxoSmithKline Services Unlimited, now comprises 1,433,361 shares or 4.47% of Maxygen. The calculation is based on a total of 32,041,239 shares outstanding in Maxygen. This decreased interest is as a result of a tender offer by Maxygen to repurchase shares, and is disclosable under the rules of the United States Securities Exchange Act of 1934.

Simon M Bicknell

Company Secretary

4 January 2010

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUSVWRRAAARAR

Investegate takes no responsibility for the accuracy of the information within the site.

The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.